<DOC>
	<DOCNO>NCT00575926</DOCNO>
	<brief_summary>Ganoderma lucidum ( Lingzhi ) Traditional Chinese Medicine widely use mean 'strengthen immunity ' among patient cancer . However , publish randomize controlled clinical trial efficacy safety despite many vitro study anti-viral , anti-oxidative , anti-tumour , radioprotective , hepato-protective immunomodulatory effect . This study randomize , double-blind , placebo-controlled , parallel clinical trial investigate benefit safety Ganoderma lucidum ( Lingzhi ) treat child cancer . Patients randomize receive identical capsule either Lingzhi placebo six month . The primary outcome general Paediatric Quality Life score . Secondary outcome include immune function , infection-related morbidity , complete blood count serum biochemistry , overall event-free survival .</brief_summary>
	<brief_title>Lingzhi Cancer Children</brief_title>
	<detailed_description>Alternative complementary medicine widely use treat child cancer . A population-based survey British Columbia reveal use 42 % respondent . Among Chinese Hong Kong , Traditional Chinese Medicine ( TCM ) also widely practice . Some 60 % population consult TCM practitioner one time another . TCM use could date back five thousand year ago , write record available two thousand year . TCM consider integral part Chinese culture . In experience , TCM believe commonly use 'strengthen immunity promote health ' among local child cancer , despite lack well-designed study prove usefulness . Ganoderma lucidum ( Ling Zhi ) mushroom long-used China broad range disorder . Its use common general population among adult child wide range malignancy . However , randomize control trial support clinical efficacy safety . Therefore , conduct clinical trial Ganoderma lucidum ( Ling Zhi ) among Hong Kong child cancer .</detailed_description>
	<criteria>Male female patient age 218 year Acute lymphoblastic leukaemia complete induction chemotherapy pending maintenance chemotherapy treatment Solid tumour complete chemotherapy Aute myeloid leukaemia complete induction consolidation chemotherapy treatment All patient parent sign informed write consent Relapsed cancer patient Received Traditional Chinese Medicine ( TCM ) treatment within precede one month Could swallow capsule Syndromal disorder ( e.g . Down syndrome ) History hypersensitivity reaction Lingzhi TCM Significant gastrointestinal , renal , hepatic , bronchopulmonary , neurological , cardiovascular allergic disease In judgement investigator unable comply study protocol requirement</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Randomized control trial</keyword>
	<keyword>Lingzhi</keyword>
	<keyword>Immune function</keyword>
	<keyword>Quality life</keyword>
	<keyword>Survival</keyword>
</DOC>